FI853193L - Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat. - Google Patents

Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.

Info

Publication number
FI853193L
FI853193L FI853193A FI853193A FI853193L FI 853193 L FI853193 L FI 853193L FI 853193 A FI853193 A FI 853193A FI 853193 A FI853193 A FI 853193A FI 853193 L FI853193 L FI 853193L
Authority
FI
Finland
Prior art keywords
ylpiperazinderivat
smaertstillande
benzisotiazol
Prior art date
Application number
FI853193A
Other languages
English (en)
Other versions
FI853193A0 (fi
FI82039B (fi
FI82039C (fi
Inventor
David W Smith
Joseph P Yevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI853193A0 publication Critical patent/FI853193A0/fi
Publication of FI853193L publication Critical patent/FI853193L/fi
Publication of FI82039B publication Critical patent/FI82039B/fi
Application granted granted Critical
Publication of FI82039C publication Critical patent/FI82039C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI853193A 1984-08-23 1985-08-20 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-benzisotiazol-3-ylpiperazinderivat. FI82039C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/643,614 US4590196A (en) 1984-08-23 1984-08-23 Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
US64361484 1984-08-23

Publications (4)

Publication Number Publication Date
FI853193A0 FI853193A0 (fi) 1985-08-20
FI853193L true FI853193L (fi) 1986-02-24
FI82039B FI82039B (fi) 1990-09-28
FI82039C FI82039C (fi) 1991-01-10

Family

ID=24581577

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853193A FI82039C (fi) 1984-08-23 1985-08-20 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-benzisotiazol-3-ylpiperazinderivat.

Country Status (22)

Country Link
US (1) US4590196A (fi)
JP (1) JPS61112063A (fi)
KR (1) KR920008820B1 (fi)
AT (1) AT396685B (fi)
AU (1) AU586182B2 (fi)
BE (1) BE903106A (fi)
CA (1) CA1249587A (fi)
CH (1) CH667268A5 (fi)
DE (1) DE3530089A1 (fi)
DK (1) DK381485A (fi)
ES (1) ES8704485A1 (fi)
FI (1) FI82039C (fi)
FR (1) FR2569404B1 (fi)
GB (1) GB2163432B (fi)
GR (1) GR852017B (fi)
IE (1) IE58608B1 (fi)
IT (1) IT1187730B (fi)
LU (1) LU86051A1 (fi)
NL (1) NL8502310A (fi)
PT (1) PT81007B (fi)
SE (1) SE464304B (fi)
ZA (1) ZA856387B (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
US4999356A (en) * 1987-08-07 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 1-phenyl-3-(1-piperazinyl)-1H-indazoles
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
NZ230045A (en) 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
HUT61760A (en) * 1988-09-16 1993-03-01 Pfizer Process for producing bridged, bicyclic imides comprising 4-/4-(3-benzisothiazolyl)-1-piperazinyl/-butyl group and pharmaceutical compositions comprising such compounds
NZ233525A (en) * 1989-05-15 1991-09-25 Janssen Pharmaceutica Nv Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers and pharmaceutical compositions
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5561128A (en) * 1989-05-19 1996-10-01 Hoechst-Roussel Pharmaceuticals, Inc. N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
JP3462501B2 (ja) * 1992-11-23 2003-11-05 アベンティス・ファーマスーティカルズ・インコーポレイテツド 置換された３−（アミノアルキルアミノ）−１，２−ベンゾイソキサゾールおよび関連化合物
ATE210663T1 (de) * 1994-06-20 2001-12-15 Takeda Chemical Industries Ltd Kondensierte imidazolderivate, ihre herstellung und verwendung
JPH08157460A (ja) * 1994-12-08 1996-06-18 Sumitomo Seika Chem Co Ltd イソチアゾール誘導体の製造方法
JP3701044B2 (ja) * 1995-04-24 2005-09-28 住友精化株式会社 シアノベンゼンスルフェニルハライドおよびそれを用いる３−置換ベンゾイソチアゾールの製造方法
HUP9802492A3 (en) * 1995-06-06 1999-10-28 Hoechst Marion Roussel Inc Cin Benzisoxazole and indazole derivatives as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same
RU2147302C1 (ru) * 1995-11-07 2000-04-10 Пфайзер Инк. 2-цианфенилтиопроизводные и способ получения 3-(1-пиперазинил)-1,2- бензизотиазола
JP3996228B2 (ja) * 1996-10-11 2007-10-24 住友精化株式会社 ３−ピペラジニルベンズイソチアゾール類の製造法
DE19651038A1 (de) * 1996-12-09 1998-06-10 Bayer Ag Verfahren zur Herstellung von 3-Chlorbenzisothiazolen
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
JP2002541098A (ja) * 1999-04-06 2002-12-03 セプラコア インコーポレーテッド ジプラシドン代謝産物を用いる神経弛緩薬性障害および関連障害を治療するための方法および組成物
US20050049295A1 (en) * 2003-06-12 2005-03-03 Dr. Reddy's Laboratories Limited Process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate
EP1853573A1 (en) * 2005-02-25 2007-11-14 Rigel Pharmaceuticals, Inc. Benzisothiazoles useful for treating or preventing hcv infection
CN100387583C (zh) * 2006-05-19 2008-05-14 浙江工业大学 一种3-氯-1,2-苯并异噻唑类化合物的合成方法
CN102040563B (zh) * 2009-10-16 2014-04-16 上海开拓者化学研究管理有限公司 一种3-芳基苯并[d]异噻唑的制备方法
CN102040564B (zh) * 2009-10-16 2012-11-21 上海开拓者化学研究管理有限公司 一种3-胺基苯并[d]异噻唑的制备方法
EP2554543B1 (en) 2010-04-02 2015-01-21 Sumitomo Seika Chemicals CO. LTD. Method for producing 3-halo-1,2-benzisothiazoles
WO2013014665A1 (en) 2011-07-28 2013-01-31 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
CN103204823B (zh) * 2013-03-18 2015-07-15 寿光新泰精细化工有限公司 一种1,2-苯并异噻唑-3-酮的提纯方法
CN105037293A (zh) * 2015-06-04 2015-11-11 大丰跃龙化学有限公司 一种bit生产中固废再利用工艺
TWI704145B (zh) * 2015-06-05 2020-09-11 芬蘭商奧利安公司 新醫藥化合物
CN106543107B (zh) * 2016-11-04 2019-02-01 山东铂源药业有限公司 一种1-boc-哌嗪的合成方法
CN108794424A (zh) * 2018-07-16 2018-11-13 连云港市三联化工有限公司 一种bit的溶剂精制方法
CN116283820A (zh) * 2023-03-23 2023-06-23 寿光新泰精细化工有限公司 3-卤代-1,2-苯并异噻唑的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670907B2 (de) * 1967-08-16 1976-07-22 Bayer Ag, 5090 Leverkusen N-disubstituierte 3-amino-1,2benzisothiazole und verfahren in ihrer herstellung
US4112105A (en) * 1977-05-04 1978-09-05 Sterling Drug Inc. Anti-inflammatory 3-(substituted-amino)-2,1-benzisothiazoles
US4104388A (en) * 1977-05-23 1978-08-01 E. R. Squibb & Sons, Inc. 3-Substituted benzisothiazole, 1,1-dioxides
US4396770A (en) * 1982-04-09 1983-08-02 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines
JPS5815965A (ja) * 1981-07-23 1983-01-29 Nippon Tokushu Noyaku Seizo Kk ベンゾイソチアゾ−ル誘導体並びにその塩酸塩、その製法、及び農業用殺菌剤
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives

Also Published As

Publication number Publication date
FI853193A0 (fi) 1985-08-20
AU4653385A (en) 1986-02-27
DK381485A (da) 1986-02-24
BE903106A (fr) 1986-02-24
US4590196A (en) 1986-05-20
GB8521050D0 (en) 1985-09-25
CA1249587A (en) 1989-01-31
IT1187730B (it) 1987-12-23
ES546347A0 (es) 1987-04-01
SE8503922L (sv) 1986-02-24
FI82039B (fi) 1990-09-28
KR920008820B1 (ko) 1992-10-09
JPS61112063A (ja) 1986-05-30
FR2569404A1 (fr) 1986-02-28
ZA856387B (en) 1986-04-30
IE852067L (en) 1986-02-23
IE58608B1 (en) 1993-10-20
SE464304B (sv) 1991-04-08
ES8704485A1 (es) 1987-04-01
ATA246985A (de) 1993-03-15
GB2163432B (en) 1988-06-22
AU586182B2 (en) 1989-07-06
IT8521968A0 (it) 1985-08-22
KR860001807A (ko) 1986-03-22
FI82039C (fi) 1991-01-10
AT396685B (de) 1993-11-25
CH667268A5 (de) 1988-09-30
GR852017B (fi) 1985-12-24
PT81007A (en) 1985-09-01
NL8502310A (nl) 1986-03-17
PT81007B (pt) 1987-12-30
SE8503922D0 (sv) 1985-08-22
LU86051A1 (fr) 1986-02-28
DK381485D0 (da) 1985-08-22
DE3530089A1 (de) 1986-03-06
FR2569404B1 (fr) 1988-07-01
GB2163432A (en) 1986-02-26

Similar Documents

Publication Publication Date Title
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
FI851114L (fi) Lagringsstabila, snabbt soederfallande farmaceutiska aktivaemnespresstycken.
FI850993L (fi) Utryckningsfordon, speciellt tankslaeckningsfordon foer flygfaelt.
FI851937A0 (fi) Utryckningsfordon, saerskilt brandbil.
FI851505L (fi) Valsanordning, speciellt foer en kalander.
FI841948A (fi) Kanna, speciellt termoskanna.
FI851383L (fi) Polyfosfat innehaollande, flytande tvaettmedelskomposition foer tvaettinraettningar.
MX21592A (es) 1,3-oxazolidin-2-ona.
FI851935A0 (fi) Utryckningsfordon, saosom brandbil.
FI840878A (fi) Ventilations-/vaermevaexlarsystem foer djurskydd, saerskilt broilerhoenshus.
FI852899A0 (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
FI853686A0 (fi) Foerfarande foer framstaellning av 2,4 -diklor-5-fluorbensoesyra.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI851743A0 (fi) Saekerhetsfoerslutningskork, saerskilt foer flaskor foer farmaceutiskt bruk.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI843996A0 (fi) Kluvet braensle-element foer kaernreaktor, isynnerhet foer kokvattenreaktor.
FI851206L (fi) Isoleringskaerl, saerskilt termoskanna.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI853585L (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
FI852372A0 (fi) Foerfarande foer framstaellning av substituerade 1,3-dioxanderivat.
FI902521A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 6,6-etylen-15,16-metylen-3-oxo-17a-pregn-4-en-21,17 -karbolaktoner.
FI842639A0 (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.
FI843391A (fi) Foerfarande foer framstaellning av osymmetriska 1,4-dihydropyridin dikarboxylsyraestrar.
IT8419415A0 (it) Composti 5, 6, 7,8-tetraidroimidazopiridinici.
FI841205A0 (fi) Planerings-, konstruerings- och styrningsfoerfarande foer anrikningsverk, speciellt foer malningsapparature malningsapparaturer.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY